Annual out-of-pocket expenditure associated with healthcare use among Australian older women with osteoporosis: a cross-sectional study.
Complementary medicine
Healthcare
Osteoporosis
Out-of-pocket expenditure
Journal
Archives of osteoporosis
ISSN: 1862-3514
Titre abrégé: Arch Osteoporos
Pays: England
ID NLM: 101318988
Informations de publication
Date de publication:
04 10 2021
04 10 2021
Historique:
received:
05
08
2021
accepted:
28
09
2021
entrez:
4
10
2021
pubmed:
5
10
2021
medline:
29
10
2021
Statut:
epublish
Résumé
This research aimed to determine the health care cost and utilisation of older Australian women with osteoporosis. A wide range of healthcare services were used and approximately AU$593.9 was spent over a 12-month period for these services. This highlights the significant cost burden of osteoporosis on the healthcare system. Osteoporosis is a common skeletal condition among women that has a considerable impact on quality of life. The purpose of this study is to determine the prevalence of healthcare use and to estimate associated out-of-pocket expenditure for the management of osteoporosis in older Australian women. Data was obtained from 393 Australian women from the 45 and Up Study who had osteoporosis. The women were asked about healthcare use for their osteoporosis, including conventional medicine, complementary medicine, and self-care practices or self-care products, and associated out-of-pocket expenditure for that use over 12 months. The average age of participants was 72.0 years. Over a 12-month period, the majority of participants (72%) consulted a doctor for their osteoporosis, 24% consulted an allied health practitioner, and 20% consulted a complementary medicine practitioner. Participants had a mean of 6.8 consultations with healthcare practitioners in the previous 12 months for the osteoporosis. In addition, 46% participants used three or more types of complementary medicine products/practices in the previous 12 months. Overall, the participants incurred a (arithmetic) mean ofAU$594 (median = $350; inter-quartile range = $450) in out-of-pocket expenditure for healthcare use over the 12-month period. Women with osteoporosis use a wide range of healthcare services that are associated with significant annual out-of-pocket expenditure. Preventive strategies can help decrease the cost burden of osteoporosis on the healthcare system.
Identifiants
pubmed: 34606032
doi: 10.1007/s11657-021-01021-5
pii: 10.1007/s11657-021-01021-5
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
148Informations de copyright
© 2021. International Osteoporosis Foundation and National Osteoporosis Foundation.
Références
Tu KN, Lie JD, Wan CKV et al (2018) Osteoporosis: a review of treatment options. Pharmacy and Therapeutics 43(2):92
pubmed: 29386866
pmcid: 5768298
Viswanathan HN, Curtis JR, Yu J et al (2012) Direct healthcare costs of osteoporosis-related fractures in managed care patients receiving pharmacological osteoporosis therapy. Appl Health Econ Health Policy 10(3):163–173
doi: 10.2165/11598590-000000000-00000
Fujiwara S, Zhao X, Teoh C, Jaffe DH, Taguchi Y (2019) Disease burden of fractures among patients with osteoporosis in Japan: health-related quality of life, work productivity and activity impairment, healthcare resource utilization, and economic costs. J Bone Miner Metab 37(2):307–318
doi: 10.1007/s00774-018-0916-1
Ha Y-C, Kim H-Y, Jang S, Lee Y-K, Kim T-Y (2017) Economic burden of osteoporosis in South Korea: claim data of the national health insurance service from 2008 to 2011. Calcif Tissue Int 101(6):623–630
doi: 10.1007/s00223-017-0320-1
Henry MJ, Pasco JA, Nicholson GC, Kotowicz MA (2011) Prevalence of osteoporosis in Australian men and women: Geelong Osteoporosis Study. Med J Aust 195(6):321–322
doi: 10.5694/mja11.10571
Johnell O, Kanis J (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17(12):1726–1733
doi: 10.1007/s00198-006-0172-4
Kanis JA (2019) Diagnosis and clinical aspects of osteoporosis. Springer, Pocket reference to osteoporosis, pp 11–20
Lewiecki EM, Ortendahl JD, Vanderpuye‐Orgle J, et al. (2019) Healthcare policy changes in osteoporosis can improve outcomes and reduce costs in the United States. JBMR plus. 3(9):e10192.
Wu J, Qu Y, Wang K, Chen Y (2019) Healthcare resource utilization and direct medical costs for patients with osteoporotic fractures in China. Value in health regional issues 18:106–111
doi: 10.1016/j.vhri.2018.11.008
Jaleel A, Saag KG, Danila MI (2018) Improving drug adherence in osteoporosis: an update on more recent studies. Therapeutic advances in musculoskeletal disease 10(7):141–149
doi: 10.1177/1759720X18785539
He J-B, Chen M-H, Lin D-K (2017) New insights into the tonifying kidney-yin herbs and formulas for the treatment of osteoporosis. Arch Osteoporos 12(1):14
doi: 10.1007/s11657-016-0301-4
Armstrong AR, Thiébaut SP, Brown LJ, Nepal B (2011) Australian adults use complementary and alternative medicine in the treatment of chronic illness: a national study. Aust N Z J Public Health 35(4):384–390
doi: 10.1111/j.1753-6405.2011.00745.x
Adams J, Andrews G, Barnes J, Broom A, Magin P (2012) Traditional, complementary and integrative medicine: an international reader: Macmillan International Higher Education.
Banu J, Varela E, Fernandes G (2012) Alternative therapies for the prevention and treatment of osteoporosis. Nutr Rev 70(1):22–40
doi: 10.1111/j.1753-4887.2011.00451.x
Habibi Ghahfarrokhi S, Reisi R (2019) Effects of medicinal herbs on osteoporosis: a systematic review based on clinical trials. Journal of Shahrekord University of Medical Sciences
Lips P, Van Schoor NM (2011) The effect of vitamin D on bone and osteoporosis. Best Pract Res Clin Endocrinol Metab 25(4):585–591
doi: 10.1016/j.beem.2011.05.002
Taku K, Melby MK, Nishi N, Omori T, Kurzer MS (2011) Soy isoflavones for osteoporosis: an evidence-based approach. Maturitas 70(4):333–338
doi: 10.1016/j.maturitas.2011.09.001
Pan H, Jin R, Li M, Liu Z, Xie Q, Wang P (2018) The effectiveness of acupuncture for osteoporosis: a systematic review and meta-analysis. Am J Chin Med 46(03):489–513
doi: 10.1142/S0192415X18500258
Zhang Y, Chai Y, Pan X, Shen H, Wei X, Xie Y (2019) Tai chi for treating osteopenia and primary osteoporosis: a meta-analysis and trial sequential analysis. Clin Interv Aging 14:91
doi: 10.2147/CIA.S187588
Mughal N, Inderjeeth AJ, Inderjeeth CA (2019) Osteoporosis in patients with dementia is associated with high morbidity and mortality: ‘findings from a single orthogeriatric unit.’ Australian journal of general practice 48(1/2):53–58
doi: 10.31128/AJGP-04-18-4544
Duckett S, Willcox S (2015) The Australian health care system: Oxford University Press
Carpenter A, Islam MM, Yen L, Mcrae I (2015) Affordability of out-of-pocket health care expenses among older Australians. Health Policy 119(7):907–914
doi: 10.1016/j.healthpol.2015.03.010
Chong C, Diaz-Granados N, Hawker G, Jamal S, Josse R, Cheung A (2007) Complementary and alternative medicine use by osteoporosis clinic patients. Osteoporos Int 18(11):1547–1556
doi: 10.1007/s00198-007-0417-x
Mak JC, Faux S (2010) Complementary and alternative medicine use by osteoporotic patients in Australia (CAMEO-A): a prospective study. The Journal Of Alternative and Complementary Medicine 16(5):579–584
doi: 10.1089/acm.2009.0425
Collaborators US (2008) Cohort profile: the 45 and up study. Int J Epidemiol 37(5):941–947
doi: 10.1093/ije/dym184
Rural A (2004) Regional and remote health: a guide to remoteness classifications. Canberra: Australian Institute of Health and Welfare AIHW Cat. No. PHE. 53
NSW Government (2019) HealthStats NSW. http://www.healthstats.nsw.gov.au/indicator/dem_pop_age . Accessed 19 July 2021
Australian Bureau of Statistics (2016) Australian Demographic Statistics, Population by age and sex. Canberra: Australian Bureau of Statistics; June 2016
Statistics ABo (2018) 4364.0. 55.001‐National Health Survey First Results, Australia 2017–2018
Steel A, McIntyre E, Harnett J et al (2018) Complementary medicine use in the Australian population: results of a nationally-representative cross-sectional survey. Sci Rep 8(1):1–7
Lefevre A, Hopper I, McNeil JJ, Owen A (2021) Complementary medicine use by community-dwelling older Australians. Med J Aust 214(3):140–141
doi: 10.5694/mja2.50884
von Conrady DM, Bonney A (2017) Patterns of complementary and alternative medicine use and health literacy in general practice patients in urban and regional Australia. Aust Fam Physician 46(5):315–324
Ercan E, Ibci S (2018) Use of complementary and alternative medicine by osteoporosis and osteopenia patients. Int J Caring Sci 11(3):1546–1556
McLaughlin D, Lui C-W, Adams J (2012) Complementary and alternative medicine use among older Australian women-a qualitative analysis. BMC Complement Altern Med 12(1):1–8
doi: 10.1186/1472-6882-12-34
Vestergaard P, Hermann P, Jensen J-E, Eiken P, Mosekilde L (2012) Effects of paracetamol, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and opioids on bone mineral density and risk of fracture: results of the Danish Osteoporosis Prevention Study (DOPS). Osteoporos Int 23(4):1255–1265
doi: 10.1007/s00198-011-1692-0
Gosch M, Jeske M, Kammerlander C, Roth T (2012) Osteoporosis and polypharmacy. Z Gerontol Geriatr 45(6):450–454
doi: 10.1007/s00391-012-0374-7
Kirby ER, Broom AF, Sibbritt DW, Refshauge KM, Adams J (2013) Health care utilisation and out-of-pocket expenditure associated with back pain: a nationally representative survey of Australian women. PloS one. 8(12):e83559
Navin Cristina TJ, Stewart Williams JA, Parkinson L, Sibbritt DW, Byles JE (2016) Identification of diabetes, heart disease, hypertension and stroke in mid-and older-aged women: comparing self-report and administrative hospital data records. Geriatr Gerontol Int 16(1):95–102
doi: 10.1111/ggi.12442